Clinical Trials Market Global Estimated to Witness Significant Growth at a 5.7% CAGR Over the Forecast & Foreseen 2023
Jul 5, 2019
Clinical Trials are Medical Investigations to Use for Research and Testing Purposes for the Evaluation of the Accuracy, Efficiency, and Effects of New Medical Treatments on Human health.
Pune, India - July 5, 2019 /MarketersMedia/ —
Global Clinical Trials Market Highlights:
According to a detailed report published by Market Research Future (MRFR), the Global Clinical Trial Market has been assessed to grow exponentially at a CAGR of 5.7% over the forecast period.
The global clinical trials market is expected to grow owing to influential factors such as the rising demand for clinical trials due to the global expansion of the healthcare sectors, increasing expenditure towards research and development of the pharmaceutical industry, growing prevalence of chronic diseases, and the focus on the treatment methods for rare diseases.
Get Premium Free Sample Report at https://www.marketresearchfuture.com/sample_request/7787
Key Players:
The key players identified in the global clinical market are Charles River Laboratories, Clinipace, Eli Lilly and Company, ICON plc, Laboratory Corporation of America, Novo Nordisk A/S, Paraxel International Corporation, Pfizer, Quintiles IMS, SGS SA, among others.
Segmental Analysis:
The global clinical trials market has been segmented based on phase, study design, indication, end users, and region.
Based on the phase, the market has been segmented into phase I, phase II, phase III, and phase IV. Among these, the phase III trial segment has been assessed to lead the market as the largest segment, owing to its high value in the healthcare sector, as well as its comparatively superior effectiveness. Phase I trial segment has been expected to grow at the fastest growth rate during the forecast period, owing to the increase in its applications in investigative new drug (IND) sector, technological advancements, and the rising government initiatives to improve the healthcare sector in emerging economies.
Based on the study design, the global clinical trials market has been segmented into expanded access interventional, and observational.
Based on indication, the global clinical trials market has been segmented into autoimmune/inflammation, cardiovascular, central nervous system (CNS) condition, diabetes, obesity, oncology, pain management, and others.
Based on the end-user, the clinical trials market is segmented into dental hospitals & clinics, dental institutes, and dental academic and research institutes.
Based on the region, the global clinical trials market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).
Regional Analysis:
The Americas have been assessed to dominate the global clinical trials market owing to the presence of multiple major pharmaceutical companies, rise in the patient population, and the increasing innovations towards product development. Additionally, the growing cases of patients suffering from chronic diseases such as cancer, diabetes, and other life-threatening diseases increases the demand for innovative drugs and contributes to the improvement of clinical trial methods to expand treatment options. These factors are also estimated to drive the clinical trials market in the region over the forecast period.
Europe has been identified as the second leading regional market for clinical trials, owing to factors such as an increase in the expenditure towards research and development in the pharmaceutical industry, and growing prevalence of chronic diseases is predictable to give a further boost to the clinical trial market. Additionally, favorable government regulations for clinical trials further support the market growth in the region and increases the demand for new products across Europe, which will consequently lead to market growth over the forecast period.
Browse Complete 110 Pages Premium Research Report Enabled With Respective Tables And Figures At https://www.marketresearchfuture.com/reports/clinical-trials-market-7787
The Asia Pacific region has been assessed as the fastest growing market for clinical trials during the forecast period, owing to the increasing incidence of diseases, growing focus of the governments on developing medications for rare diseases and the growth in the export sector contributes substantially to the clinical trial market in the region. In countries like India, China, and Australia, the developing economy and low cost to operate clinical trial facilities supply the market growth in this region.
The Middle East & Africa has been estimated to witness slow, gradual growth in the global clinical trials market over the forecast period, owing to the presence of weak economies, lesser technical amenities, lack of medical knowledge, and limited clinical trials centers, especially in the African region decrease the market growth. The Middle East has been expected to contribute the majority of the market share in this region, due to the presence of a well-established healthcare sector and huge healthcare expenditure by the governments of countries like Saudi Arabia, Kuwait, and Qatar.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers, , Magarpatta Road, Hadapsar,, , Pune - 411028, , Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/clinical-trials-market-7787
Source: MarketersMedia
Release ID: 88893115
More News
The wealthy Cuban Americans ready and waiting for Havana to fall
Cuban exiles in Florida are increasingly hopeful that regime change in Cuba is now on the horizon.
What to Know About Trump Accounts as More Than 60 Million Children Are Auto-Enrolled
The Trump administration may have just signed up your child — and more than 60 million others — for a 530A savings account (if you haven’t already done so).
U.S. Bond Yields Hit Highest Level Since 2002
The higher yields, which are pressuring consumer and corporate borrowers and increasingly weighing on certain corners of the stock market, are unlikely to dissipate soon.
PM warned Rosebank oil field could breach West Bank sanctions
Campaigners and Green Party leader Zack Polanski raise concerns about Rosebank's ties to an Israeli firm.
HMRC urged to scrutinise tax implications of Man City case
The Treasury Committee, which is responsible for overseeing HMRC, has urged the body to scrutinise tax implications of the Manchester City verdict.
As Mortgage Rates Hit Highest Level Since 2023, Buyers Look at ARMs
The average 30-year, fixed-rate home loan rose to 7.28 percent, up from 6.34 percent a year ago. More buyers are now turning to adjustable-rate mortgages.
Thames Water apologises after £145,000 customer billing mistake
The firm has apologised to the family.
Help! Air Canada Got Me to Europe, Then Stranded Me There.
The airline helpfully rebooked a delayed traveler from Toronto, but failed to mention it had also canceled her return trip. She spent $800 to get home.
Travelodge failed sex assault victim 'at every stage'
Room intrusions were still being reported at one-in-10 Travelodge hotels this summer, a review finds.
Swedish Company Uses A.I. Likeness of Greta Garbo in Ad
An ad produced by the manufacturing company SKF Group featured a digital version of the Swedish American actress, who died in 1990. Not all viewers found the replica convincing.
'We must keep going' says charity hit by fuel prices
Both petrol and diesel prices have risen by a third or more in just the past seven months.
Is it time to ditch premium bonds?
Martin Lewis says though they are the UK's most popular form of savings, not everybody benefits from them. Martin explains who premium bonds are best for, and who they aren’t so good for.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.